cladribine has been researched along with Seizures in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dang, YL; Kalincik, T; Perucca, P; Sharmin, S; Yong, VT | 1 |
| Delannoy, A; Doyen, C; Ferrant, A; Martiat, P; Michaux, JL; Montfort, L; Sokal, G | 1 |
1 review(s) available for cladribine and Seizures
| Article | Year |
|---|---|
Seizure risk in multiple sclerosis patients treated with disease-modifying therapy: A systematic review and network meta-analysis.
Topics: Anticonvulsants; Bayes Theorem; Cladribine; Humans; Multiple Sclerosis; Network Meta-Analysis; Seizures | 2023 |
1 trial(s) available for cladribine and Seizures
| Article | Year |
|---|---|
2-Chlorodeoxyadenosine therapy in advanced chronic lymphocytic leukaemia.
Topics: Aged; Cladribine; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neutropenia; Remission Induction; Salvage Therapy; Seizures; Survival Rate; Thrombocytopenia; Treatment Outcome | 1994 |